The main risks of corneal transplantation include graft rejection, secondary glaucoma, and infection. While success rates are high, approximately 20-30% of full-thickness transplants experience rejection. Patients must monitor for sudden redness, pain, or decreased vision, which require immediate medical intervention to prevent permanent graft failure.
- Graft rejection: Immune system attacks donor tissue, most commonly within 6–24 months post-surgery.
- Secondary glaucoma: Increased eye pressure often linked to long-term steroid eye drop use.
- Post-operative astigmatism: Irregular corneal shape frequently requiring corrective lenses or additional surgical adjustment.
- Cataract development: Clouding of the natural lens often accelerates 3–5 years after transplantation.
Bookimed Expert Insight: Data from high-volume Turkish centers like Dunyagoz Eye Hospital, which treats 66,000 patients annually, shows that surgeon experience directly impacts safety. Specialists like Dr. Muhammet Derda Ozer have performed over 25,000 eye surgeries. Choosing a doctor with this level of volume significantly reduces the risk of technical complications during complex partial-thickness grafts.
Patient Consensus: Patients emphasize that strict adherence to a lifelong eye drop schedule is the only way to prevent silent rejection. Many noted that secondary issues like cataracts or astigmatism are common but manageable with follow-up procedures.